Agonist dynamics and conformational selection during microsecond simulations of the A2A adenosine receptor

Biophysical Journal

Volumn 102, Issue 9, 2012, Pages 2114-2120

  Lee, Ji Young ^a   Lyman, Edward ^a  

^a UNIVERSITY OF DELAWARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR;

ARTICLE; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; PROTEIN CONFORMATION; PROTEIN SUBUNIT; ULTRASTRUCTURE;

ADENOSINE; ADENOSINE A2 RECEPTOR AGONISTS; COMPUTER SIMULATION; MODELS, CHEMICAL; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN SUBUNITS; RECEPTOR, ADENOSINE A2A;

EID: 84860448544     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2012.03.061     Document Type: Article

References (36)

1. A. Gilchrist GPCR Molecular Pharmacology and Drug Targeting 2010 John Wiley & Sons Hoboken, NJ
2. M. Congreve, and F.H. Marshall The impact of GPCR structures on pharmacology and structure-based drug design Br. J. Pharmacol. 159 2010 986 996
3. M. Congreve, and C.J. Langmead F.H. Marshall Progress in structure based drug design for G protein-coupled receptors J. Med. Chem. 54 2011 4283 4311
4. 2A receptor in a high-affinity antagonist-bound state: implications for GPCR drug screening and design Curr. Opin. Struct. Biol. 20 2010 401 414
5. B.B. Fredholm, and A.P. IJzerman C.E. Müller International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors - an update Pharmacol. Rev. 63 2011 1 34
6. 2A adenosine receptor bound to an antagonist Science 322 2008 1211 1217
7. T. Hino, and T. Arakawa T. Murata G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody Nature 482 2012 237 240
8. 2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine Structure 19 2011 1283 1293
9. 2A adenosine receptor Science 332 2011 322 327
10. 2A receptor structures reveal common features of GPCR activation Nature 474 2011 521 525
11. 2A adenosine receptor Structure 17 2009 1660-8
12. Michelle A. O'Malley, Matthew E. Helgeson Norman J. Wagner, and Anne S. Robinson Biophys. J. 101 2011 1938 1948
13. D. Rodríguez, Á. Piñeiro, and H. Gutiérrez-de- Terán Molecular dynamics simulations reveal insights into key structural elements of adenosine receptors Biochemistry 50 2011 4194 4208
14. K. Martínez-Mayorga, and M.C. Pitman M.F. Brown Retinal counterion switch mechanism in vision evaluated by molecular simulations J. Am. Chem. Soc. 128 2006 16502 16503
15. A. Grossfield, and M.C. Pitman K. Gawrisch Internal hydration increases during activation of the G-protein-coupled receptor rhodopsin J. Mol. Biol. 381 2008 478 486
16. E. Jardón-Valadez, A.-N. Bondar, and D.J. Tobias Coupling of retinal, protein, and water dynamics in squid rhodopsin Biophys. J. 99 2010 2200 2207
17. 2) adrenergic receptor revealed by microsecond timescale molecular dynamics Biophys. J. 98 2010 76 84
18. R.O. Dror, and A.C. Pan D.E. Shaw Pathway and mechanism of drug binding to G-protein-coupled receptors Proc. Natl. Acad. Sci. USA 108 2011 13118 13123
19. 2-adrenergic receptor reconciles structural and biochemical observations Proc. Natl. Acad. Sci. USA 106 2009 4689 4694
20. D.P. Hurst, and A. Grossfield P.H. Reggio A lipid pathway for ligand binding is necessary for a cannabinoid G protein-coupled receptor J. Biol. Chem. 285 2010 17954 17964
21. J.W. Daly Adenosine receptors: targets for future drugs J. Med. Chem. 25 1982 197 207
22. S.M. Poucher, and J.R. Keddie M.G. Coll The in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonist Br. J. Pharmacol. 115 1995 1096 1102
23. M.A. Lomize, and A.L. Lomize H.I. Mosberg OPM: orientations of proteins in membranes database Bioinformatics 22 2006 623 625
24. A.D. MacKerell Jr., and D. Bashford M. Karplus All-atom empirical potential for molecular modeling and dynamics studies of proteins J. Phys. Chem. B 102 1998 3586 3616
25. J.B. Klauda, and R.M. Venable R.W. Pastor Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types J. Phys. Chem. B 114 2010 7830 7843
26. K. Vanommeslaeghe, and E. Hatcher A.D. Mackerell Jr. CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields J. Comput. Chem. 31 2010 671 690
27. K.J. Bowers, and E. Chow D.E. Shaw Scalable algorithms for molecular dynamics simulations on commodity clusters Proc. ACM/IEEE SC2006 Conf., Tampa, FL 2006
28. G.J. Martyna, D.J. Tobias, and M.L. Klein Constant pressure molecular dynamics algorithms J. Chem. Phys. 101 1994 4177 4189
29. W. Humphrey, A. Dalke, and K. Schulten VMD: visual molecular dynamics J. Mol. Graph. 14 1996 33 38 27-28
30. H. Flyvbjerg, and H.G. Petersen Error estimates on averages of correlated data J. Chem. Phys. 91 1989 461 466
31. T.D. Romo, and A. Grossfield LOOS: an extensible platform for the structural analysis of simulations Conf. Proc. IEEE Eng. Med. Biol. Soc. 2009 2009 2332 2335
32. J.R. Lakowicz Principles of Fluorescence Spectroscopy 1983 Plenum Press New York
33. V.-P. Jaakola, and J.R. Lane R.C. Stevens Ligand binding and subtype selectivity of the human A(2A) adenosine receptor: identification and characterization of essential amino acid residues J. Biol. Chem. 285 2010 13032 13044
34. 2a adenosine receptor J. Biol. Chem. 270 1995 13987 13997
35. 2A receptor J. Phys. Chem. B 115 2011 13880 13890
36. P.J. Conn, A. Christopoulos, and C.W. Lindsley Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders Nat. Rev. Drug Discov. 8 2009 41 54